How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

[11] Resch C(2011)The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up Enferm Infecc Microbiol Clin 29 645-653

[12] Munoz-Moreno JA(2019)PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in England BMJ Open 9 e025497-537

[13] Miners A(2004)The Menopause Rating Scale (MRS) scale: a methodological review Health Qual Life Outcomes 2 45-621

[14] Phillips A(2018)Severe menopausal symptoms associated with reduced adherence to antiretroviral therapy among perimenopausal and menopausal women living with HIV in Metro Vancouver Menopause (New York, NY) 25 531-95

[15] Kreif N(2009)An ultra-brief screening scale for anxiety and depression: the PHQ-4 Psychosomatics 50 613-237

[16] Rodger A(2010)A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population J Affect Disord 122 86-340

[17] Speakman A(2008)A confirmatory factor analysis of an abbreviated social support instrument: the MOS-SS Res Soc Work Pract 18 231-108

[18] Fisher M(2021)Effectiveness and safety of antiretroviral treatment in pre- and postmenopausal women living with HIV in a multicentre cohort Antiviral Ther 25 335-824

[19] Ferreira CE(2021)The association between severe menopausal symptoms and engagement with HIV care and treatment in women living with HIV AIDS Care 33 101-1524

[20] Pinto-Neto AM(2012)Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women Menopause (New York, NY) 19 820-72

[11] Resch C(2011)The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up Enferm Infecc Microbiol Clin 29 645-653

[12] Munoz-Moreno JA(2019)PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in England BMJ Open 9 e025497-537

[13] Miners A(2004)The Menopause Rating Scale (MRS) scale: a methodological review Health Qual Life Outcomes 2 45-621

[14] Phillips A(2018)Severe menopausal symptoms associated with reduced adherence to antiretroviral therapy among perimenopausal and menopausal women living with HIV in Metro Vancouver Menopause (New York, NY) 25 531-95

[15] Kreif N(2009)An ultra-brief screening scale for anxiety and depression: the PHQ-4 Psychosomatics 50 613-237

[16] Rodger A(2010)A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population J Affect Disord 122 86-340

[17] Speakman A(2008)A confirmatory factor analysis of an abbreviated social support instrument: the MOS-SS Res Soc Work Pract 18 231-108

[18] Fisher M(2021)Effectiveness and safety of antiretroviral treatment in pre- and postmenopausal women living with HIV in a multicentre cohort Antiviral Ther 25 335-824

[19] Ferreira CE(2021)The association between severe menopausal symptoms and engagement with HIV care and treatment in women living with HIV AIDS Care 33 101-1524

[20] Pinto-Neto AM(2012)Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women Menopause (New York, NY) 19 820-72